Latest Breaking News On - Caution concerning forward looking - Page 1 : comparemela.com

Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024

/PRNewswire/ Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced long-term follow-up results, including the first-ever overall survival (OS) findings,.

Germany
Texas
United-states
Ireland
Japan
Spain
Italy
China
France
Dublin
American
Kristin-bhavnani

EnerSys : reg; Introduces NexSys®+ Outdoor Chargers

EnerSys : reg; Introduces NexSys®+ Outdoor Chargers
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Switzerland
Harold-vanasse
Energy-systems
Enersys
Introduces-nexsys
Outdoor-chargers
Senior-director
Motive-power-global
Motive-power
Caution-concerning-forward-looking
Private-securities-litigation-reform-act

Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer

Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Japan
Germany
Ireland
Dublin
Spain
Italy
France
China
American
Andrean-flynn
Kristin-bhavnani

TILT : Investor Presentation – March 2024 -March 25, 2024 at 05:43 pm EDT

Caution Concerning Forward-Looking Statements This presentation contains forward-looking information and statements under applicable Canadian and U.S. securities.

United-states
Canada
Massachusetts
Ohio
Canadian
Our-mission
Exchange-commission
Caution-concerning-forward-looking
Annual-report
Quarterly-reports
States-securities

Abbott Reports Fourth-Quarter and Full-Year 2023 Results; Issues 2024 Financial Outlook

/PRNewswire/ Abbott today announced financial results for the fourth quarter ended Dec. 31, 2023..

United-states
China
Canada
America
Prnewswire-abbott
Robertb-ford
Linkedin
Cardiovascular-systems-inc
Tandem-diabetes-care-inc
Acelis-connected-health
Drug-administration
European-union-medical-device-regulations